Veradermics, Incorporated (MANE) stock analysis

In our weekly check, Veradermics, Incorporated is graded D (A to F). Of 15 checks on debt, profit, cash flow and trend: 5 pass, warnings: 3, red flags: 7.

About Veradermics, Incorporated

Veradermics, Incorporated is a Healthcare company (Biotechnology) based in the United States, listed on NYSE as MANE.

What our checks show for MANE

Red flags

Warning signs

Strengths

Similar companies

ERAS · PTCT · SRRK · DNTH · COGT · EWTX

Questions

What grade does Veradermics, Incorporated (MANE) have?

In our weekly check, Veradermics, Incorporated is graded D (A to F). Of 15 checks on debt, profit, cash flow and trend: 5 pass, warnings: 3, red flags: 7. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of MANE stock?

This week's biggest flags for Veradermics, Incorporated: Weak interest cover, Weak EPS forecast, Thin margins. In total 10 of 15 checks show a warning or a red flag.

What does Veradermics, Incorporated do?

Veradermics, Incorporated is a Healthcare company (Biotechnology) based in the United States, listed on NYSE as MANE.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-11-14

Open the full analysis